The risk of recurrent stroke during the first few days after a transient ischaemic attack or
minor stroke is much higher than previously estimated. However, there is substantial …

Ischemic stroke results in demyelination that underlies neurological disfunction. Promoting
oligodendrogenesis will rescue the injured axons and accelerate remyelination after stroke …

Stroke is the third leading cause of death and the leading cause of long-term disability in the
United States. Approximately 80% of all strokes are ischemic and there are limited therapies …

Cardiopulmonary arrest is one of the leading causes of death and disability, primarily
occurring in the aged population. Numerous global cerebral ischemia animal models induce …

Cerebral ischemia is one of the most devastating brain injuries and a primary cause of
acquired and persistent disability worldwide. Despite ongoing therapeutic interventions at …

There is a compelling need to develop cell and pharmacological therapeutic approaches to
be administered beyond the hyperacute phase of stroke. These therapies capitalize on the …

Evidence of oxidative stress is apparent in both acute and chronic neurodegenerative
diseases, such as stroke, Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) …

Despite the discovery of several promising neuroprotective therapies in rodent models of
stroke, no therapy other than the fibrinolytics has been found to be effective in human clinical …

With an incidence of approximately 350 in 100,000, stroke is the third leading cause of death
and a major cause of disability in industrialized countries. At present, although progress has …

We examined the effects of age on stroke progression and outcome in order to explore the
association between blood–brain barrier (BBB) disruption, neuronal damage, and functional …